SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $170,000 | +1.8% | 15,175 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $167,000 | +1.8% | 15,175 | -9.5% | 0.00% | 0.0% |
| Q1 2017 | $164,000 | 0.0% | 16,775 | +10.6% | 0.00% | 0.0% |
| Q4 2016 | $164,000 | +5.8% | 15,168 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $155,000 | +33.6% | 15,168 | +43.8% | 0.00% | 0.0% |
| Q1 2016 | $116,000 | +7.4% | 10,548 | -10.4% | 0.00% | 0.0% |
| Q4 2015 | $108,000 | +31.7% | 11,773 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $82,000 | -29.3% | 11,773 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $116,000 | +11.5% | 11,773 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $104,000 | +1.0% | 11,773 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $103,000 | +33.8% | 11,773 | +5.6% | 0.00% | 0.0% |
| Q3 2014 | $77,000 | +20.3% | 11,148 | -7.8% | 0.00% | 0.0% |
| Q2 2014 | $64,000 | -61.2% | 12,088 | -66.7% | 0.00% | -50.0% |
| Q1 2014 | $165,000 | -10.3% | 36,303 | -0.4% | 0.00% | 0.0% |
| Q4 2013 | $184,000 | -6.1% | 36,463 | -5.5% | 0.00% | 0.0% |
| Q3 2013 | $196,000 | – | 38,573 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |